Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Joshi

Showing results (721-730 of 781) with videos related to

Pageof 79
Sort By:
Nature Immunology|January 22, 2020
Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadthKrishna M Roskin, Katherine J L Jackson, Ji-Yeun Lee, et al.
South Asian Journal of Cancer|December 30, 2016
Oncology Gold Standard™ practical consensus recommendations 2016 for treatment of advanced clear cell renal cell carcinoma, U Batra, P M Parikh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
A phase I and pharmacokinetic study of losoxantrone and paclitaxel in patients with advanced solid tumorsS G Diab, S D Baker, A Joshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinibDavid M Jackman, Beow Y Yeap, Lecia V Sequist, et al.
Esophagus : Official Journal of the Japan Esophageal Society|May 25, 2022
Oral metronomic chemotherapy after definitive chemoradiation in esophageal squamous cell carcinoma: a randomized clinical trialV Noronha, V M Patil, N S Menon, et al.
ESMO Open|March 15, 2025
The impact of co-occurring tumor suppressor mutations with mEGFR as early indicators of relapse in lung cancerS Hait, V Noronha, A Chowdhury, et al.
Journal of the American College of Cardiology|November 1, 2020
Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19Jesus Alvarez-Garcia, Samuel Lee, Arjun Gupta, et al.
Nature Genetics|May 19, 2015
Genome-wide maps of recombination and chromosome segregation in human oocytes and embryos show selection for maternal recombination ratesChristian S Ottolini, Louise Newnham, Antonio Capalbo, et al.
Clinical Transplantation|February 22, 2021
No survival benefit associated with waiting for non-lung donor heart transplants for adult recipients with congenital heart diseaseMichael J Diamant, Arieh L Fox, Vivek A Modi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Epidermal growth factor receptor mutation testing in the care of lung cancer patientsLecia V Sequist, Victoria A Joshi, Pasi A Jänne, et al.
Pageof 79

Showing results (721-730 of 781) with videos related to

Sort By:
Pageof 79
Nature Immunology|January 22, 2020
Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadthKrishna M Roskin, Katherine J L Jackson, Ji-Yeun Lee, et al.
South Asian Journal of Cancer|December 30, 2016
Oncology Gold Standard™ practical consensus recommendations 2016 for treatment of advanced clear cell renal cell carcinoma, U Batra, P M Parikh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
A phase I and pharmacokinetic study of losoxantrone and paclitaxel in patients with advanced solid tumorsS G Diab, S D Baker, A Joshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinibDavid M Jackman, Beow Y Yeap, Lecia V Sequist, et al.
Esophagus : Official Journal of the Japan Esophageal Society|May 25, 2022
Oral metronomic chemotherapy after definitive chemoradiation in esophageal squamous cell carcinoma: a randomized clinical trialV Noronha, V M Patil, N S Menon, et al.
ESMO Open|March 15, 2025
The impact of co-occurring tumor suppressor mutations with mEGFR as early indicators of relapse in lung cancerS Hait, V Noronha, A Chowdhury, et al.
Journal of the American College of Cardiology|November 1, 2020
Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19Jesus Alvarez-Garcia, Samuel Lee, Arjun Gupta, et al.
Nature Genetics|May 19, 2015
Genome-wide maps of recombination and chromosome segregation in human oocytes and embryos show selection for maternal recombination ratesChristian S Ottolini, Louise Newnham, Antonio Capalbo, et al.
Clinical Transplantation|February 22, 2021
No survival benefit associated with waiting for non-lung donor heart transplants for adult recipients with congenital heart diseaseMichael J Diamant, Arieh L Fox, Vivek A Modi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Epidermal growth factor receptor mutation testing in the care of lung cancer patientsLecia V Sequist, Victoria A Joshi, Pasi A Jänne, et al.
Pageof 79